adp-a2m4cd8,nivolumab
bms,adaptimmune therapeutics
['surpass', '$adap']
 great $adap mage-a4 targeting #tcr t-cell trial #surpass update for all 44 patients at #esmo22 and with todays additional confirmed responses and further improvements at the analyst event 
born to be me, expect the worst - go for the best
 { views are my own - tweets are not advice }